查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2030 年奈米生物技術市場預測 - 依類型、治療方法、技術、用途和地區進行的全球分析
市場調查報告書
商品編碼
1358969

2030 年奈米生物技術市場預測 - 依類型、治療方法、技術、用途和地區進行的全球分析

Nanobiotechnology Market Forecasts to 2030 - Global Analysis By Type (10-100 Nm and 0-10 Nm), Therapeutic (Orthopedic Therapies, Dental Therapies, Cardiac Therapies, Liposomes and Other Therapeutics), Technology, Application and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據Stratistics MRC的數據，2023年全球奈米生物技術市場規模為1,126.6億美元，預計到2030年將達到1,869.1億美元，預測期內年複合成長率為7.5%。

在奈米級層面上對生物系統的研究，通常涉及分子和微粒，被稱為奈米生物技術，是奈米技術和生物技術領域的融合。與奈米生物技術同時使用的其他術語包括奈米生物學和生物奈米技術。透過在小於100奈米的尺度上操縱物質來生產和使用材料、設備和系統，統稱為「奈米生物技術應用」。在全球範圍內，政府和公司正在大力投資奈米生物技術。

根據聯合國糧食及農業組織預測，到 2050 年，世界人口預計將超過 97 億。

慢性病增加

奈米生物技術市場的關鍵成長促進因素是全球癌症、糖尿病和心血管疾病等慢性病患病的上升。奈米生物技術為某些疾病的常規治療方法問題提供了更好的解決方案。例如，基於奈米顆粒的藥物傳輸系統可以實現加護治療，從而減少副作用並改善患者的治療效果。隨著全球慢性病負擔的增加，對創造性奈米生物技術解決方案的需求不斷增加。

開發成本高

奈米生物技術產品的開發和商業化需要對基礎設施、專業設備、人員以及研發活動進行大量投資。然而，奈米生物技術的高開發成本可能會成為一種阻礙力，特別是對於財力有限的新興企業（SME）而言。為了突破這一障礙，獲得資本和投資機會至關重要。

增加奈米生物技術的投資

越來越多的新穎性、原創和未來性的產品正在進行臨床試驗，這可能會加速全球奈米生物技術市場的發展。世界各地的公司和政府正在大力投資奈米生物技術。此外，許多政府機構正在增加對奈米生物技術研究和進步的投資。公司正積極投資研發，將新產品推向市場。在奈米生物技術領域，這些創新工具正在為公司帶來競爭優勢。

毒性和長期影響

奈米生物技術利用具有特殊性能和潛在危險的奈米級材料。因此，法規機構在認證和行銷奈米生物技術產品時一直存在擔憂。由於對奈米材料毒性及其對人類健康和環境的長期影響的安全擔憂，預計將加強審查和審查。因此，這些要素預計將在預測期內阻礙奈米生物技術市場的擴張。

COVID-19 的影響：

COVID-19 的爆發凸顯了快速準確診斷以及開發高效能藥物和疫苗的重要性。奈米生物技術能夠提高診斷測試的敏感性和特異性並增強藥物傳輸系統，在這兩個領域都具有重要意義。對醫療保健解決方案的關注可能加速了奈米生物技術產業的擴張。政府和私人投資者可能已將資金和資源轉移到與 COVID-19 相關領域的研究和開發。可能會向專注於病毒相關主題的奈米生物技術公司提供更多資金。

預計在預測期內，製藥領域將是最大的產業。

預計在預測期內，製藥領域將佔據最大佔有率。藥品製造和分銷使用奈米級材料、設備和程序。此外，該領域有潛力改變藥物開發、輸送和治療效果，從而為各種疾病提供更個體化和集中的治療。

預計整形外科治療領域在預測期內將經歷最高的年複合成長率。

由於奈米材料、藥物傳輸系統和專為整形外科設計的診斷設備的開發取得了重大進展，整形外科治療領域預計將在預測期內實現有益成長。此外，透過使用奈米顆粒和奈米複合材料等奈米材料，奈米生物技術能夠將標靶藥物輸送到受傷組織，提高治療的生物利用度並支持組織再生。奈米級影像方式也改善了整形外科疾病的早期檢測和監測。

比最大的地區

預計北美在預測期內將佔據最大佔有率。穩定的法規環境為該地區奈米生物技術的發展創造了良好的氛圍。美國FDA 和其他法規機構與公司和研究人員密切合作，以確保奈米技術產品的功效和安全性。此外，產業合作和政府的大力支持是該區域市場成功的關鍵要素。

複合年複合成長率最高的地區：

由於成功的臨床試驗和最終食品藥物管理局(FDA) 批准推動製藥和生物技術行業良好的成長前景，預計歐洲將預測最高的成長。區域市場擴張的主要促進因素是對技術先進產品的需求不斷成長以及研發設施的擴張。預計有助於區域市場擴張的其他方面包括生物技術部門的擴張、政府投資和配合措施、癌症研究和靶向藥物、農業和環境應用以及電子設備和材料領域的奈米技術。

免費客製化服務

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和年複合成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章 執行摘要

第2章 前言

  • 概述
  • 利害關係人
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章 市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 技術分析
  • 應用分析
  • 新興市場
  • 新型冠狀病毒感染疾病（COVID-19）的影響

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代的威脅
  • 新進入者的威脅
  • 競爭公司之間的敵對關係

第5章 全球奈米生物技術市場：依類型

  • 10～100Nm
  • 0～10Nm

第6章 全球奈米生物技術市場：依治療方法

  • 整形外科治療
  • 牙科治療
  • 心臟治療
  • 脂質體
  • 其他治療方法

第7章 全球奈米生物技術市場：依技術分類

  • 奈米粒子
  • 奈米殼
  • 奈米管
  • 其他技術

第8章 全球奈米生物技術市場：依用途

  • 基因組學
  • 藥物輸送
  • 蛋白質體學
  • 藥品
  • 糧食和農業
  • 醫療設備
  • 醫學研究
  • 其他用途

第9章 全球奈米生物技術市場：依地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第10章 進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第11章公司簡介

  • Abbott Laboratories
  • Advanced Nano Products Co., Ltd
  • Altair Nanotechnologies Inc
  • Biosensors International Group, Ltd
  • Bruker Corporation
  • Calando Pharmaceuticals
  • Celgene Corporation
  • Dendritic Nanotechnologies
  • Elan Pharmaceuticals
  • eSpin Technologies, Inc
  • Flamel Technologies
  • Imina Technologies SA
  • Johnson & Johnson
  • Nano Bridging Molecules SA
  • Novartis AG
  • Thermo Fisher Scientific Inc
  • XanTecbioanalytics GmbH
Product Code: SMRC23841

According to Stratistics MRC, the Global Nanobiotechnology Market is accounted for $112.66 billion in 2023 and is expected to reach $186.91 billion by 2030 growing at a CAGR of 7.5% during the forecast period. The study of biological systems at the nanoscale level, often including molecules and microscopic particles, is known as nanobiotechnology and is a blend of the nanotechnology and biotechnology fields. Other terms that are used simultaneously with nanobiotechnology include nanobiology and bionanotechnology. The production and usage of materials, devices, and systems through the manipulation of matter at scales smaller than 100 nanometers are collectively referred to as "nanobiotechnology applications. Globally, governments and businesses are investing heavily in nanobiotechnology.

According to Food & Agriculture Organization, the world population is anticipated to surpass 9.7 billion by 2050.

Market Dynamics:

Driver:

Increased incidence of chronic diseases

A significant growth driver for the nanobiotechnology market is the rising prevalence of chronic diseases, including cancer, diabetes, and cardiovascular problems, around the world. Better solutions to problems with conventional therapies for certain illnesses are provided by nanobiotechnology. For instance, focused therapy is made possible by nanoparticle-based drug delivery systems, which also reduce side effects and enhance patient outcomes. The need for creative nanobiotechnology solutions is growing as the burden of chronic diseases increases globally.

Restraint:

High development expenses

Nanobiotechnology products require large investments in infrastructure, specialized equipment, staff, and research and development activities in order to be developed and commercialized. However, nanobiotechnology's high development costs might be a deterrent, especially for startups or small and medium-sized businesses (SMEs) with restricted funding sources. To break through this barrier, access to capital and investment possibilities is essential.

Opportunity:

Increasing investments in nanobiotechnology

A rise in the quantity of novel, inventive, and promising products undergoing clinical trials will accelerate the development of the global nanobiotechnology market. Businesses and governments around the world are making significant investments in nanobiotechnology. Additionally, many government organizations have increased the amount of money that is invested in the study and advancement of nanobiotechnology. To bring novel products to market, businesses are actively investing in research and development. In the nanobiotechnology sector, these innovative tools give businesses a competitive advantage.

Threat:

Toxicity and long term impacts

Nanobiotechnology makes use of materials at the nanoscale, which have special qualities and potential hazards. Because of this, regulatory bodies have been concerned while certifying and releasing nanobiotechnology products for sale. It is anticipated that increased scrutiny and oversight will be required due to safety concerns over the toxicity and long-term impacts of nanomaterials on human health and the environment. Thus, during the course of the forecast period, these factors are anticipated to hinder the expansion of the nanobiotechnology market.

COVID-19 Impact:

The COVID-19 epidemic has highlighted the significance of quick and precise diagnosis as well as the creation of efficient medications and vaccinations. With the ability to increase the sensitivity and specificity of diagnostic tests and enhance drug delivery systems, nanobiotechnology is significant in both fields. The focus on healthcare solutions may have accelerated the expansion of the nanobiotechnology industry. Funds and resources may have been transferred by governments and private investors to research and development in COVID-19-related fields. There may have been more funding available for nanobiotechnology companies focusing on virus-related topics.

The pharmaceuticals segment is expected to be the largest during the forecast period

Pharmaceuticals segment is expected to hold largest share over the projection period. In the manufacturing and distribution of pharmaceutical products, nanoscale materials, devices, and procedures are used. Additionally, this area has the potential to transform medication development, delivery, and therapeutic efficacy, enabling more individualized and focused treatments for a range of illnesses.

The orthopedic therapies segment is expected to have the highest CAGR during the forecast period

Due to significant advances in the creation of nanomaterials, drug delivery systems, and diagnostic instruments specifically designed for orthopedic purposes, the orthopedic therapies segment is anticipated to experience profitable growth over the course of the projected period. Additionally, through the use of nanomaterials like nanoparticles and nanocomposites, nanobiotechnology enables targeted drug delivery to injured tissues, improves the bioavailability of treatments, and supports tissue regeneration. The early detection and monitoring of orthopedic disorders are also being improved by nanoscale imaging and diagnostic methods.

Region with largest share:

North America is expected to hold largest share over the projection period. A stable regulatory environment created a favorable atmosphere for the development of nanobiotechnology in the region. The FDA and other regulatory bodies in the US collaborated closely with businesses and researchers to guarantee the efficacy and safety of nanotech products. Additionally, industry collaboration and robust government support are key factors in the regional market's success.

Region with highest CAGR:

Due to favorable growth prospects for the pharmaceutical and biotechnology industries brought on by successful clinical trials and eventual Food and Drug Administration (FDA) certification, Europe is expected to have the highest growth. The main drivers of regional market expansion are the increasing demand for technologically advanced products and well-developed R&D facilities. Other aspects that are anticipated to contribute to regional market expansion include the expanding biotechnology sector, government investments and efforts, cancer research and targeted medicines, agriculture and environmental applications, and nanotechnology in electronics and materials.

Key players in the market:

Some of the key players in Nanobiotechnology market include: Abbott Laboratories, Advanced Nano Products Co., Ltd, Altair Nanotechnologies Inc, Biosensors International Group, Ltd, Bruker Corporation, Calando Pharmaceuticals, Celgene Corporation, Dendritic Nanotechnologies, Elan Pharmaceuticals, eSpin Technologies, Inc, Flamel Technologies, Imina Technologies SA, Johnson & Johnson, Nano Bridging Molecules SA, Novartis AG, Thermo Fisher Scientific Inc and XanTecbioanalytics GmbH.

Key Developments:

In September 2023, Abbott has entered a definitive agreement for the acquisition of Bigfoot Biomedical, which develops smart insulin management systems for individuals with diabetes.

Types Covered:

  • 10-100 Nm
  • 0-10 Nm

Therapeutics Covered:

  • Orthopedic Therapies
  • Dental Therapies
  • Cardiac Therapies
  • Liposomes
  • Other Therapeutics

Technologies Covered:

  • Nanoparticles
  • Nanoshells
  • Nanotubes
  • Other Technologies

Applications Covered:

  • Genomics
  • Drug Delivery
  • Proteomics
  • Pharmaceuticals
  • Food and Agriculture
  • Medical Devices
  • Medical Research
  • Other Applications

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Technology Analysis
  • 3.7 Application Analysis
  • 3.8 Emerging Markets
  • 3.9 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Nanobiotechnology Market, By Type

  • 5.1 Introduction
  • 5.2 10-100 Nm
  • 5.3 0-10 Nm

6 Global Nanobiotechnology Market, By Therapeutic

  • 6.1 Introduction
  • 6.2 Orthopedic Therapies
  • 6.3 Dental Therapies
  • 6.4 Cardiac Therapies
  • 6.5 Liposomes
  • 6.6 Other Therapeutics

7 Global Nanobiotechnology Market, By Technology

  • 7.1 Introduction
  • 7.2 Nanoparticles
  • 7.3 Nanoshells
  • 7.4 Nanotubes
  • 7.5 Other Technologies

8 Global Nanobiotechnology Market, By Application

  • 8.1 Introduction
  • 8.2 Genomics
  • 8.3 Drug Delivery
  • 8.4 Proteomics
  • 8.5 Pharmaceuticals
  • 8.6 Food and Agriculture
  • 8.7 Medical Devices
  • 8.8 Medical Research
  • 8.9 Other Applications

9 Global Nanobiotechnology Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Abbott Laboratories
  • 11.2 Advanced Nano Products Co., Ltd
  • 11.3 Altair Nanotechnologies Inc
  • 11.4 Biosensors International Group, Ltd
  • 11.5 Bruker Corporation
  • 11.6 Calando Pharmaceuticals
  • 11.7 Celgene Corporation
  • 11.8 Dendritic Nanotechnologies
  • 11.9 Elan Pharmaceuticals
  • 11.10 eSpin Technologies, Inc
  • 11.11 Flamel Technologies
  • 11.12 Imina Technologies SA
  • 11.13 Johnson & Johnson
  • 11.14 Nano Bridging Molecules SA
  • 11.15 Novartis AG
  • 11.16 Thermo Fisher Scientific Inc
  • 11.17 XanTecbioanalytics GmbH

List of Tables

  • Table 1 Global Nanobiotechnology Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Nanobiotechnology Market Outlook, By Type (2021-2030) ($MN)
  • Table 3 Global Nanobiotechnology Market Outlook, By 10-100 Nm (2021-2030) ($MN)
  • Table 4 Global Nanobiotechnology Market Outlook, By 0-10 Nm (2021-2030) ($MN)
  • Table 5 Global Nanobiotechnology Market Outlook, By Therapeutic (2021-2030) ($MN)
  • Table 6 Global Nanobiotechnology Market Outlook, By Orthopedic Therapies (2021-2030) ($MN)
  • Table 7 Global Nanobiotechnology Market Outlook, By Dental Therapies (2021-2030) ($MN)
  • Table 8 Global Nanobiotechnology Market Outlook, By Cardiac Therapies (2021-2030) ($MN)
  • Table 9 Global Nanobiotechnology Market Outlook, By Liposomes (2021-2030) ($MN)
  • Table 10 Global Nanobiotechnology Market Outlook, By Other Therapeutics (2021-2030) ($MN)
  • Table 11 Global Nanobiotechnology Market Outlook, By Technology (2021-2030) ($MN)
  • Table 12 Global Nanobiotechnology Market Outlook, By Nanoparticles (2021-2030) ($MN)
  • Table 13 Global Nanobiotechnology Market Outlook, By Nanoshells (2021-2030) ($MN)
  • Table 14 Global Nanobiotechnology Market Outlook, By Nanotubes (2021-2030) ($MN)
  • Table 15 Global Nanobiotechnology Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 16 Global Nanobiotechnology Market Outlook, By Application (2021-2030) ($MN)
  • Table 17 Global Nanobiotechnology Market Outlook, By Genomics (2021-2030) ($MN)
  • Table 18 Global Nanobiotechnology Market Outlook, By Drug Delivery (2021-2030) ($MN)
  • Table 19 Global Nanobiotechnology Market Outlook, By Proteomics (2021-2030) ($MN)
  • Table 20 Global Nanobiotechnology Market Outlook, By Pharmaceuticals (2021-2030) ($MN)
  • Table 21 Global Nanobiotechnology Market Outlook, By Food and Agriculture (2021-2030) ($MN)
  • Table 22 Global Nanobiotechnology Market Outlook, By Medical Devices (2021-2030) ($MN)
  • Table 23 Global Nanobiotechnology Market Outlook, By Medical Research (2021-2030) ($MN)
  • Table 24 Global Nanobiotechnology Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 25 North America Nanobiotechnology Market Outlook, By Country (2021-2030) ($MN)
  • Table 26 North America Nanobiotechnology Market Outlook, By Type (2021-2030) ($MN)
  • Table 27 North America Nanobiotechnology Market Outlook, By 10-100 Nm (2021-2030) ($MN)
  • Table 28 North America Nanobiotechnology Market Outlook, By 0-10 Nm (2021-2030) ($MN)
  • Table 29 North America Nanobiotechnology Market Outlook, By Therapeutic (2021-2030) ($MN)
  • Table 30 North America Nanobiotechnology Market Outlook, By Orthopedic Therapies (2021-2030) ($MN)
  • Table 31 North America Nanobiotechnology Market Outlook, By Dental Therapies (2021-2030) ($MN)
  • Table 32 North America Nanobiotechnology Market Outlook, By Cardiac Therapies (2021-2030) ($MN)
  • Table 33 North America Nanobiotechnology Market Outlook, By Liposomes (2021-2030) ($MN)
  • Table 34 North America Nanobiotechnology Market Outlook, By Other Therapeutics (2021-2030) ($MN)
  • Table 35 North America Nanobiotechnology Market Outlook, By Technology (2021-2030) ($MN)
  • Table 36 North America Nanobiotechnology Market Outlook, By Nanoparticles (2021-2030) ($MN)
  • Table 37 North America Nanobiotechnology Market Outlook, By Nanoshells (2021-2030) ($MN)
  • Table 38 North America Nanobiotechnology Market Outlook, By Nanotubes (2021-2030) ($MN)
  • Table 39 North America Nanobiotechnology Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 40 North America Nanobiotechnology Market Outlook, By Application (2021-2030) ($MN)
  • Table 41 North America Nanobiotechnology Market Outlook, By Genomics (2021-2030) ($MN)
  • Table 42 North America Nanobiotechnology Market Outlook, By Drug Delivery (2021-2030) ($MN)
  • Table 43 North America Nanobiotechnology Market Outlook, By Proteomics (2021-2030) ($MN)
  • Table 44 North America Nanobiotechnology Market Outlook, By Pharmaceuticals (2021-2030) ($MN)
  • Table 45 North America Nanobiotechnology Market Outlook, By Food and Agriculture (2021-2030) ($MN)
  • Table 46 North America Nanobiotechnology Market Outlook, By Medical Devices (2021-2030) ($MN)
  • Table 47 North America Nanobiotechnology Market Outlook, By Medical Research (2021-2030) ($MN)
  • Table 48 North America Nanobiotechnology Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 49 Europe Nanobiotechnology Market Outlook, By Country (2021-2030) ($MN)
  • Table 50 Europe Nanobiotechnology Market Outlook, By Type (2021-2030) ($MN)
  • Table 51 Europe Nanobiotechnology Market Outlook, By 10-100 Nm (2021-2030) ($MN)
  • Table 52 Europe Nanobiotechnology Market Outlook, By 0-10 Nm (2021-2030) ($MN)
  • Table 53 Europe Nanobiotechnology Market Outlook, By Therapeutic (2021-2030) ($MN)
  • Table 54 Europe Nanobiotechnology Market Outlook, By Orthopedic Therapies (2021-2030) ($MN)
  • Table 55 Europe Nanobiotechnology Market Outlook, By Dental Therapies (2021-2030) ($MN)
  • Table 56 Europe Nanobiotechnology Market Outlook, By Cardiac Therapies (2021-2030) ($MN)
  • Table 57 Europe Nanobiotechnology Market Outlook, By Liposomes (2021-2030) ($MN)
  • Table 58 Europe Nanobiotechnology Market Outlook, By Other Therapeutics (2021-2030) ($MN)
  • Table 59 Europe Nanobiotechnology Market Outlook, By Technology (2021-2030) ($MN)
  • Table 60 Europe Nanobiotechnology Market Outlook, By Nanoparticles (2021-2030) ($MN)
  • Table 61 Europe Nanobiotechnology Market Outlook, By Nanoshells (2021-2030) ($MN)
  • Table 62 Europe Nanobiotechnology Market Outlook, By Nanotubes (2021-2030) ($MN)
  • Table 63 Europe Nanobiotechnology Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 64 Europe Nanobiotechnology Market Outlook, By Application (2021-2030) ($MN)
  • Table 65 Europe Nanobiotechnology Market Outlook, By Genomics (2021-2030) ($MN)
  • Table 66 Europe Nanobiotechnology Market Outlook, By Drug Delivery (2021-2030) ($MN)
  • Table 67 Europe Nanobiotechnology Market Outlook, By Proteomics (2021-2030) ($MN)
  • Table 68 Europe Nanobiotechnology Market Outlook, By Pharmaceuticals (2021-2030) ($MN)
  • Table 69 Europe Nanobiotechnology Market Outlook, By Food and Agriculture (2021-2030) ($MN)
  • Table 70 Europe Nanobiotechnology Market Outlook, By Medical Devices (2021-2030) ($MN)
  • Table 71 Europe Nanobiotechnology Market Outlook, By Medical Research (2021-2030) ($MN)
  • Table 72 Europe Nanobiotechnology Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 73 Asia Pacific Nanobiotechnology Market Outlook, By Country (2021-2030) ($MN)
  • Table 74 Asia Pacific Nanobiotechnology Market Outlook, By Type (2021-2030) ($MN)
  • Table 75 Asia Pacific Nanobiotechnology Market Outlook, By 10-100 Nm (2021-2030) ($MN)
  • Table 76 Asia Pacific Nanobiotechnology Market Outlook, By 0-10 Nm (2021-2030) ($MN)
  • Table 77 Asia Pacific Nanobiotechnology Market Outlook, By Therapeutic (2021-2030) ($MN)
  • Table 78 Asia Pacific Nanobiotechnology Market Outlook, By Orthopedic Therapies (2021-2030) ($MN)
  • Table 79 Asia Pacific Nanobiotechnology Market Outlook, By Dental Therapies (2021-2030) ($MN)
  • Table 80 Asia Pacific Nanobiotechnology Market Outlook, By Cardiac Therapies (2021-2030) ($MN)
  • Table 81 Asia Pacific Nanobiotechnology Market Outlook, By Liposomes (2021-2030) ($MN)
  • Table 82 Asia Pacific Nanobiotechnology Market Outlook, By Other Therapeutics (2021-2030) ($MN)
  • Table 83 Asia Pacific Nanobiotechnology Market Outlook, By Technology (2021-2030) ($MN)
  • Table 84 Asia Pacific Nanobiotechnology Market Outlook, By Nanoparticles (2021-2030) ($MN)
  • Table 85 Asia Pacific Nanobiotechnology Market Outlook, By Nanoshells (2021-2030) ($MN)
  • Table 86 Asia Pacific Nanobiotechnology Market Outlook, By Nanotubes (2021-2030) ($MN)
  • Table 87 Asia Pacific Nanobiotechnology Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 88 Asia Pacific Nanobiotechnology Market Outlook, By Application (2021-2030) ($MN)
  • Table 89 Asia Pacific Nanobiotechnology Market Outlook, By Genomics (2021-2030) ($MN)
  • Table 90 Asia Pacific Nanobiotechnology Market Outlook, By Drug Delivery (2021-2030) ($MN)
  • Table 91 Asia Pacific Nanobiotechnology Market Outlook, By Proteomics (2021-2030) ($MN)
  • Table 92 Asia Pacific Nanobiotechnology Market Outlook, By Pharmaceuticals (2021-2030) ($MN)
  • Table 93 Asia Pacific Nanobiotechnology Market Outlook, By Food and Agriculture (2021-2030) ($MN)
  • Table 94 Asia Pacific Nanobiotechnology Market Outlook, By Medical Devices (2021-2030) ($MN)
  • Table 95 Asia Pacific Nanobiotechnology Market Outlook, By Medical Research (2021-2030) ($MN)
  • Table 96 Asia Pacific Nanobiotechnology Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 97 South America Nanobiotechnology Market Outlook, By Country (2021-2030) ($MN)
  • Table 98 South America Nanobiotechnology Market Outlook, By Type (2021-2030) ($MN)
  • Table 99 South America Nanobiotechnology Market Outlook, By 10-100 Nm (2021-2030) ($MN)
  • Table 100 South America Nanobiotechnology Market Outlook, By 0-10 Nm (2021-2030) ($MN)
  • Table 101 South America Nanobiotechnology Market Outlook, By Therapeutic (2021-2030) ($MN)
  • Table 102 South America Nanobiotechnology Market Outlook, By Orthopedic Therapies (2021-2030) ($MN)
  • Table 103 South America Nanobiotechnology Market Outlook, By Dental Therapies (2021-2030) ($MN)
  • Table 104 South America Nanobiotechnology Market Outlook, By Cardiac Therapies (2021-2030) ($MN)
  • Table 105 South America Nanobiotechnology Market Outlook, By Liposomes (2021-2030) ($MN)
  • Table 106 South America Nanobiotechnology Market Outlook, By Other Therapeutics (2021-2030) ($MN)
  • Table 107 South America Nanobiotechnology Market Outlook, By Technology (2021-2030) ($MN)
  • Table 108 South America Nanobiotechnology Market Outlook, By Nanoparticles (2021-2030) ($MN)
  • Table 109 South America Nanobiotechnology Market Outlook, By Nanoshells (2021-2030) ($MN)
  • Table 110 South America Nanobiotechnology Market Outlook, By Nanotubes (2021-2030) ($MN)
  • Table 111 South America Nanobiotechnology Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 112 South America Nanobiotechnology Market Outlook, By Application (2021-2030) ($MN)
  • Table 113 South America Nanobiotechnology Market Outlook, By Genomics (2021-2030) ($MN)
  • Table 114 South America Nanobiotechnology Market Outlook, By Drug Delivery (2021-2030) ($MN)
  • Table 115 South America Nanobiotechnology Market Outlook, By Proteomics (2021-2030) ($MN)
  • Table 116 South America Nanobiotechnology Market Outlook, By Pharmaceuticals (2021-2030) ($MN)
  • Table 117 South America Nanobiotechnology Market Outlook, By Food and Agriculture (2021-2030) ($MN)
  • Table 118 South America Nanobiotechnology Market Outlook, By Medical Devices (2021-2030) ($MN)
  • Table 119 South America Nanobiotechnology Market Outlook, By Medical Research (2021-2030) ($MN)
  • Table 120 South America Nanobiotechnology Market Outlook, By Other Applications (2021-2030) ($MN)
  • Table 121 Middle East & Africa Nanobiotechnology Market Outlook, By Country (2021-2030) ($MN)
  • Table 122 Middle East & Africa Nanobiotechnology Market Outlook, By Type (2021-2030) ($MN)
  • Table 123 Middle East & Africa Nanobiotechnology Market Outlook, By 10-100 Nm (2021-2030) ($MN)
  • Table 124 Middle East & Africa Nanobiotechnology Market Outlook, By 0-10 Nm (2021-2030) ($MN)
  • Table 125 Middle East & Africa Nanobiotechnology Market Outlook, By Therapeutic (2021-2030) ($MN)
  • Table 126 Middle East & Africa Nanobiotechnology Market Outlook, By Orthopedic Therapies (2021-2030) ($MN)
  • Table 127 Middle East & Africa Nanobiotechnology Market Outlook, By Dental Therapies (2021-2030) ($MN)
  • Table 128 Middle East & Africa Nanobiotechnology Market Outlook, By Cardiac Therapies (2021-2030) ($MN)
  • Table 129 Middle East & Africa Nanobiotechnology Market Outlook, By Liposomes (2021-2030) ($MN)
  • Table 130 Middle East & Africa Nanobiotechnology Market Outlook, By Other Therapeutics (2021-2030) ($MN)
  • Table 131 Middle East & Africa Nanobiotechnology Market Outlook, By Technology (2021-2030) ($MN)
  • Table 132 Middle East & Africa Nanobiotechnology Market Outlook, By Nanoparticles (2021-2030) ($MN)
  • Table 133 Middle East & Africa Nanobiotechnology Market Outlook, By Nanoshells (2021-2030) ($MN)
  • Table 134 Middle East & Africa Nanobiotechnology Market Outlook, By Nanotubes (2021-2030) ($MN)
  • Table 135 Middle East & Africa Nanobiotechnology Market Outlook, By Other Technologies (2021-2030) ($MN)
  • Table 136 Middle East & Africa Nanobiotechnology Market Outlook, By Application (2021-2030) ($MN)
  • Table 137 Middle East & Africa Nanobiotechnology Market Outlook, By Genomics (2021-2030) ($MN)
  • Table 138 Middle East & Africa Nanobiotechnology Market Outlook, By Drug Delivery (2021-2030) ($MN)
  • Table 139 Middle East & Africa Nanobiotechnology Market Outlook, By Proteomics (2021-2030) ($MN)
  • Table 140 Middle East & Africa Nanobiotechnology Market Outlook, By Pharmaceuticals (2021-2030) ($MN)
  • Table 141 Middle East & Africa Nanobiotechnology Market Outlook, By Food and Agriculture (2021-2030) ($MN)
  • Table 142 Middle East & Africa Nanobiotechnology Market Outlook, By Medical Devices (2021-2030) ($MN)
  • Table 143 Middle East & Africa Nanobiotechnology Market Outlook, By Medical Research (2021-2030) ($MN)
  • Table 144 Middle East & Africa Nanobiotechnology Market Outlook, By Other Applications (2021-2030) ($MN)